Autopsy report · NCT03060109

Fresh Intravenous Blood Samples for TBI Diagnostic Assay Development With Philips Point of Care System

“Diagnostic platform no longer under development; study termination not related to any safety issues”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months after it had already started.
• Ran for about 1 year 3 months before it stopped.
• 317 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Banyan Biomarkers, Inc

Sponsor type

Industry

Conditions

Traumatic Brain Injury

Interventions

Blood draw within 12 hours of injury

Participants

317

Sites

4

Countries

Netherlands

Trials that died the same way

• A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
  “Study terminated due to various reasons impacting the feasibility of future clinical development” (63% match in meaning)
• Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging
  “"Study terminated due to institutional resource constraints, including limited availability of specialized equipment and technical support. Termination was not related to participant safety, data quality, study conduct, or the investigational product” (62% match in meaning)
• A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration
  “The study terminated for safety reasons” (62% match in meaning)
• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
  “The study was terminated prematurely on May 16, 2013, for futility. No new or unexpected safety issues were identified.” (61% match in meaning)
• Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture
  “The study was terminated early due to operational feasibility challenges, including competing clinical priorities and resource constraints.” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.